Desmopressin: Clinical Trials

8 trials of Desmopressin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated, 1 recruiting. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 4, Terminated 3, Recruiting 1
Phase 31Terminated 1

Follow Desmopressin: new trials by email Literature Review of Desmopressin trials Research Report on Desmopressin

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Desmopressin, Dexamethasone - Cushing Syndrome
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1402024-12-122026-08-31
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
FE 201836, Desmopressin, Placebo oral solution - Nocturia
Phase 2CompletedFerring Pharmaceuticals3022017-07-272022-03-02
Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
Desmopressin, Fesoterodine - Nocturia
Phase 2 / Phase 3TerminatedMount Sinai Hospital, Canada42015-07-012016-11-15
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
DDAVP - Postoperative Ecchymosis
Phase 2TerminatedUniversity Hospitals Cleveland Medical Center142013-12-012023-08-16
Daytime Impact Sleep Study
Desmopressin, Placebo (not active) - Nocturia
Phase 2TerminatedFerring Pharmaceuticals52013-04-012015-04-27
Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding
Desmopressin - Colorectal Cancer, Rectal Bleeding
Phase 2CompletedLaboratorio Elea Phoenix S.A.302013-04-012017-08-24
Perioperative Use of Desmopressin (DDAVP) in Breast Cancer
Desmopressin - Breast Cancer
Phase 2CompletedLaboratorio Elea Phoenix S.A.212011-11-012015-08-28
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
Desmopressin, Placebo - Nocturia
Phase 2CompletedFerring Pharmaceuticals1162010-07-012012-05-25

Conditions studied

Nocturia (4)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Cushing Syndrome (1)  ·  Disease (1)  ·  Ecchymosis (1)  ·  Edema (1)  ·  Gastrointestinal Hemorrhage (1)

Sponsors

Ferring Pharmaceuticals (3)  ·  Laboratorio Elea Phoenix S.A. (2)  ·  Mount Sinai Hospital, Canada (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  University Hospitals Cleveland Medical Center (1)

Countries

United States (3)  ·  Argentina (2)  ·  Canada (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Bahman Guyuron, MD (1)  ·  Dra. Ruth Weinberg (1)  ·  Enrique Roca, MD (1)  ·  Harold P Drutz, MD (1)  ·  Lynnette K Nieman, M.D. (1)

Results publications

PMID 26306290, PMID 32166534, PMID 42535456

NIH funding

2016 (1)